Company intelligence / Profile preview
Hakeem Pharma
- Ownership
- Private
- Development stage
- Commercial
Overview
Hakeem Pharma is a newly established pharmaceutical manufacturer in Saudi Arabia with a 10,000 square meter facility. The company produces both human and veterinary medicines and is building out its R&D capabilities to accelerate new product development. The factory is designed to meet local and international GMP standards for registration with the SFDA and other agencies. No clinical trial results are reported yet.
- Therapeutic areas
- Other
- Modalities
- Small moleculeBiologic
- Industry
- Biotech
Drug pipeline
2 assets1 more asset in the full pipeline.
Beyond the preview
Go deeper on Hakeem Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Hakeem Pharma.